Sickle cell

Area of Science:

• Genetics
• Public Health
• Reproductive Rights

Background:

• Newborn screening for sickle cell disease (SCD) is widely implemented, ensuring early identification and care.
• However, the absence of widespread prenatal diagnosis for SCD leaves many prospective parents unaware of their child's status.
• This gap impacts family planning and reproductive decision-making.

Purpose of the Study:

• To highlight the limitations of current newborn screening protocols regarding sickle cell trait (SCT) and SCD.
• To emphasize the critical need for implementing prenatal diagnostic options for SCD.
• To advocate for parental rights to information and decision-making in reproductive healthcare.

Main Methods:

• This study is a critical review of current public health strategies for sickle cell disease.
• It analyzes the implications of newborn screening versus prenatal diagnosis.
• It examines ethical considerations related to reproductive autonomy and the right to know.

Main Results:

• Newborn screening identifies children with SCD but does not inform parents prenatally.
• Lack of prenatal diagnosis prevents parents from making informed family planning decisions.
• Pregnant women with fetuses affected by SCD are not offered the option to terminate the pregnancy.

Conclusions:

• Failure to implement prenatal diagnosis for SCD infringes upon fundamental rights to know and decide.
• Universal prenatal screening and counseling are essential for informed reproductive choices.
• Addressing this gap is crucial to alleviate lifelong burdens associated with chronic illness for affected children and families.